vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (IBCP) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $58.9M, roughly 1.3× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs 7.4%, a 21.2% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 2.1%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

IBCP vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.3× larger
VMD
$76.2M
$58.9M
IBCP
Higher net margin
IBCP
IBCP
21.2% more per $
IBCP
28.6%
7.4%
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
2.1%
IBCP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBCP
IBCP
VMD
VMD
Revenue
$58.9M
$76.2M
Net Profit
$16.9M
$5.6M
Gross Margin
57.9%
Operating Margin
11.0%
Net Margin
28.6%
7.4%
Revenue YoY
25.5%
Net Profit YoY
8.2%
30.7%
EPS (diluted)
$0.81
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBCP
IBCP
VMD
VMD
Q1 26
$58.9M
Q4 25
$58.3M
$76.2M
Q3 25
$57.3M
$71.9M
Q2 25
$55.9M
$63.1M
Q1 25
$54.1M
$59.1M
Q4 24
$62.0M
$60.7M
Q3 24
$51.4M
$58.0M
Q2 24
$56.5M
$55.0M
Net Profit
IBCP
IBCP
VMD
VMD
Q1 26
$16.9M
Q4 25
$18.6M
$5.6M
Q3 25
$17.5M
$3.5M
Q2 25
$16.9M
$3.2M
Q1 25
$15.6M
$2.6M
Q4 24
$18.5M
$4.3M
Q3 24
$13.8M
$3.9M
Q2 24
$18.5M
$1.5M
Gross Margin
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Operating Margin
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
34.8%
11.0%
Q3 25
37.0%
7.8%
Q2 25
37.0%
8.1%
Q1 25
35.3%
6.5%
Q4 24
36.7%
10.6%
Q3 24
33.7%
9.7%
Q2 24
41.0%
6.6%
Net Margin
IBCP
IBCP
VMD
VMD
Q1 26
28.6%
Q4 25
31.8%
7.4%
Q3 25
30.5%
4.9%
Q2 25
30.2%
5.0%
Q1 25
28.8%
4.4%
Q4 24
29.8%
7.1%
Q3 24
26.9%
6.7%
Q2 24
32.8%
2.7%
EPS (diluted)
IBCP
IBCP
VMD
VMD
Q1 26
$0.81
Q4 25
$0.88
$0.14
Q3 25
$0.84
$0.09
Q2 25
$0.81
$0.08
Q1 25
$0.74
$0.06
Q4 24
$0.87
$0.10
Q3 24
$0.65
$0.10
Q2 24
$0.88
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBCP
IBCP
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$174.9M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.6M
$141.5M
Total Assets
$5.6B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBCP
IBCP
VMD
VMD
Q1 26
$174.9M
Q4 25
$138.4M
$13.5M
Q3 25
$208.7M
$11.1M
Q2 25
$146.2M
$20.0M
Q1 25
$128.1M
$10.2M
Q4 24
$119.9M
$17.5M
Q3 24
$121.6M
$11.3M
Q2 24
$214.3M
$8.8M
Stockholders' Equity
IBCP
IBCP
VMD
VMD
Q1 26
$510.6M
Q4 25
$503.0M
$141.5M
Q3 25
$490.7M
$133.6M
Q2 25
$469.3M
$139.7M
Q1 25
$467.3M
$134.8M
Q4 24
$454.7M
$131.4M
Q3 24
$452.4M
$125.0M
Q2 24
$430.5M
$119.4M
Total Assets
IBCP
IBCP
VMD
VMD
Q1 26
$5.6B
Q4 25
$5.5B
$199.2M
Q3 25
$5.5B
$202.4M
Q2 25
$5.4B
$184.6M
Q1 25
$5.3B
$178.1M
Q4 24
$5.3B
$177.1M
Q3 24
$5.3B
$169.5M
Q2 24
$5.3B
$163.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBCP
IBCP
VMD
VMD
Operating Cash FlowLast quarter
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
$76.7M
$18.4M
Q3 25
$18.2M
$18.4M
Q2 25
$19.0M
$12.3M
Q1 25
$31.7M
$2.9M
Q4 24
$63.2M
$15.0M
Q3 24
$17.2M
$12.7M
Q2 24
$8.7M
$10.2M
Free Cash Flow
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
$70.2M
$9.7M
Q3 25
$16.5M
$10.7M
Q2 25
$16.7M
$4.1M
Q1 25
$30.6M
$-12.6M
Q4 24
$55.2M
$3.2M
Q3 24
$15.7M
$1.7M
Q2 24
$7.0M
$1.2M
FCF Margin
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
120.3%
12.7%
Q3 25
28.9%
14.9%
Q2 25
29.8%
6.5%
Q1 25
56.5%
-21.4%
Q4 24
89.1%
5.2%
Q3 24
30.6%
3.0%
Q2 24
12.3%
2.3%
Capex Intensity
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
11.1%
11.5%
Q3 25
2.9%
10.6%
Q2 25
4.1%
12.9%
Q1 25
2.1%
26.2%
Q4 24
12.8%
19.5%
Q3 24
2.9%
19.0%
Q2 24
3.1%
16.3%
Cash Conversion
IBCP
IBCP
VMD
VMD
Q1 26
Q4 25
4.13×
3.27×
Q3 25
1.04×
5.23×
Q2 25
1.12×
3.88×
Q1 25
2.03×
1.09×
Q4 24
3.42×
3.47×
Q3 24
1.25×
3.29×
Q2 24
0.47×
6.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBCP
IBCP

Net Interest Income$46.9M80%
Noninterest Income$12.0M20%

VMD
VMD

Segment breakdown not available.

Related Comparisons